Opko Health Inc OPK

NAS: OPK | ISIN: US68375N1037 20:33

1,340 USD (+1,52%)

(+1,52%) 20:33

Grafiek Opko Health Inc

Grafiek Opko Health Inc

1 dag1d 1,52%
1 week1w 6,35%
1 maand1m 8,94%
3 maanden3m 30,10%
6 maanden6m -9,46%
1 jaar1j -10,67%
5 jaar5j -32,66%

Opko Health Inc in het nieuws

Toon enkel gratis nieuws

28 maart 2024 · Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business · Persbericht

28 februari 2024 · NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st · Persbericht

5 februari 2024 · NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China · Persbericht

7 november 2023 · BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ · Persbericht

29 september 2023 · Thinking about buying stock in Blue Apron Holdings, OceanPal, OPKO Health, Bionomics, or Aytu Biopharma? · Persbericht

9 februari 2023 · BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings · Persbericht

16 maart 2022 · GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions · Persbericht

1 maart 2022 · Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease · Persbericht

29 november 2021 · BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S. · Persbericht

21 september 2021 · GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes · Persbericht

Profiel Opko Health Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.opko.com

Hoofdzetel: Miami, Florida Verenigde Staten

CEO: Phillip Frost

Werknemers: 339

Aandelen Opko Health Inc

Beurswaarde: 920,03 miljoen USD

Effecten: 696,99 miljoen

Winst per aandeel (12 maand): PLUS

Beta: 1,25

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe